Sporogenics is now a member of co11ab. co11ab is a Singapore biomedtech incubator formed by Nanyang Technological University (NTU), A*STAR and National Health Group (NHG) to nurture and support translational development of biomedical technologies.
Sporogenics filed a PCT patent on 10-Sep-2021 on ADHESION BARRIER COMPOSITION, METHODS OF FABRICATION AND USE THEREOF
Title (EN) ADHESION BARRIER COMPOSITION, METHODS OF FABRICATION AND USE THEREOF (FR) COMPOSITION DE BARRIÈRE ANTI-ADHÉRENCE, SES PROCÉDÉS DE FABRICATION ET SON UTILISATION Abstract (EN) The present invention relates, in general terms, to methods of reducing the formation of post-surgery tissue adhesion in a subject in need thereof by administering an adhesion barrier composition. The
Sporogenics was featured on the latest issue on an online UK magazine, please click below link to read more about Sporogenics’s story and aspiration. https://ghp-news.com/issues/q1-2021/42/
Sporogenics is honored to be the recipient of JLabs Award at MedTech Innovator Asia Pacific 2020 Grand Final for 1 year residency at Johnson & Johnson Innovation JLabs@Shanghai: https://www.businesswire.com/news/home/20201117006364/en/MedTech-Innovator-Names-X-ZELL-as-2020-Asia-Pacific-Final-Competition-Winner
Please support us to join the quest to improve surgical outcomes by preventing postsurgical adhesion! https://medtechinnovator.org/medtech-innovator-asia-pacific-finalists-2020/
Check the website for details: https://www.apacmedvirtualforum.com
Among over 180 submissions, Sporogenics is delighted to be selected as one of the 40 medtech startups for an online pitch session on 26 May 2020 during the global pandemic due to COVID-19. It was a great learning experience interacting with industry experts such as from Johnson and Johnson, Baxter, Oliver Healthcare Packaging etc.
Dec 2, 2019 Baxter International said Monday it plans to acquire Sanofi’s surgical products unit Seprafilm and related assets for $350 million in cash, confirming October speculation the Deerfield, Illinois-based healthcare products company and French pharma were weighing a deal. The deal gives Baxter’s surgery division an adhesion barrier product meant to reduce incidence and